Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Vestor Capital LLC

Vestor Capital LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,300 shares of the medical equipment provider’s stock after purchasing an additional 252 shares during the quarter. Vestor Capital LLC’s holdings in Intuitive Surgical were worth $8,008,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. Creekmur Asset Management LLC grew its stake in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the second quarter worth $26,000. Delos Wealth Advisors LLC raised its holdings in Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares in the last quarter. Godsey & Gibb Inc. boosted its stake in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares in the last quarter. Finally, LRI Investments LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at about $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.5 %

Shares of ISRG stock opened at $506.34 on Monday. The company has a market capitalization of $180.35 billion, a price-to-earnings ratio of 81.41, a P/E/G ratio of 4.95 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $269.49 and a 12-month high of $523.34. The firm has a fifty day moving average of $490.41 and a 200-day moving average of $447.59.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ISRG. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Mizuho lifted their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Morgan Stanley increased their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Amy L. Ladd sold 450 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,558,968.56. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 68,246 shares of company stock valued at $33,839,308 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.